Buscar
Mostrando ítems 1-10 de 55
Diagnosis and management of paget's disease of bone - series of 8 casesDiagnóstico e manejo da doença de paget óssea - série de 8 casos
(2019-01-01)
Paget's disease of bone is a chronic condition characterized by focal abnormalities of absorption and formation of bone, and it may lead to anatomical deformities, pain, fractures, and malignant transformation. It is common ...
Diagnosis and management of Paget?s disease of bone
(Sociedade Brasileira de Endocrinologia e Metabologia, 2014-08-01)
Objective:To conduct a literature review on the diagnosis and management of Paget’s disease of bone. Materials and methods:This scientific statement was generated by a request from the Brazilian Medical Association (AMB) ...
A Brazilian family with hereditary inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia
(Associação Brasileira de Divulgação Científica, 2011)
Inclusion body myopathy associated with Paget disease and frontotemporal dementia (IBMPFD) is a progressive and usually misdiagnosed autosomal dominant disorder. It is clinically characterized by a triad of features: ...
Enfermedad de Paget en Chile: una serie de 15 pacientes
(Sociedad Médica de Santiago, 2003)
Bone scintigraphy in testicular tumors
(2001-02-07)
Purpose: Testicular tumors do not occur frequently. Primary treatment is surgical, and radiotherapy and chemotherapy can play important roles in cases of metastatic disease. Bone scintigraphy is used largely for early ...
Bone scintigraphy in testicular tumors
(2001-02-07)
Purpose: Testicular tumors do not occur frequently. Primary treatment is surgical, and radiotherapy and chemotherapy can play important roles in cases of metastatic disease. Bone scintigraphy is used largely for early ...
Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients
(WILEY-BLACKWELL, 2011)
Osteonecrosis of the jaw (ONJ), previously an entity associated with radiation therapy to the head and neck, has been observed in patients treated with bisphosphonates. Patients with metastatic breast cancer and myelomatous ...